-
CHMP Recommends First-Line Pembrolizumab Plus Chemo for Unresectable Non-Epithelioid Malignant Pleural Mesothelioma
15 Nov 2024 19:14 GMT
… outcomes than patients with epithelioid mesothelioma,” Gregory Lubiniecki, MD, … mesothelioma.
The trial excluded patients with untreated central nervous system metastases … unresectable non-epithelioid malignant pleural mesothelioma (MPM). News release. Merck …
-
Intrapulmonary Biphasic Mesothelioma Misdiagnosed as Adenocarcinoma: Case Report and a Potential Diagnostic Pitfall
05 Nov 2024 09:59 GMT
… for the distinction of mesothelioma or breast cancer metastasis, which was diagnosed … by electron microscopy.23
Mesothelioma has … a localised malignant pleural mesothelioma with cranial metastasis. BMJ Case Rep. …
-
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
23 Oct 2024 14:05 GMT
… increasing together with liver metastasis from other primary … several tumor types with metastasis to the liver, … prognostic role of liver metastases on patient outcomes: systematic … life during chemotherapy for pleural mesothelioma: feasibility, validity, and …
-
FDA Approves Pembrolizumab/Chemo in Unresectable Pleural Mesothelioma
18 Sep 2024 06:51 GMT
… advanced or metastatic malignant pleural mesothelioma (MPM), according to a … had active central nervous system metastases and/or carcinomatous meningitis … patients with advanced malignant pleural mesothelioma. ClinicalTrials.gov. Updated January 16 …
-
FDA Approves Pembrolizumab Plus Chemo for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
18 Sep 2024 01:45 GMT
… advanced or metastatic malignant pleural mesothelioma. Patients needed to have measurable … no known central nervous system metastases unless treated and stable.
Study … advanced or metastatic malignant pleural mesothelioma. FDA. September 17, 2024. Accessed …
-
FDA Grants ISM6331 Investigational New Drug Clearance to Treat Mesothelioma
15 Aug 2024 17:51 GMT
… humans for the treatment of mesothelioma.
The approval, known as Investigational … :
Cancer metabolism
Drug resistance
Immunity
Metastasis (cancer spread)
Tumor progression
By … clinical trials.
Get Help Finding Mesothelioma Clinical Trials & Care
If …
-
Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment
09 Aug 2024 02:50 GMT
… for the treatment of mesothelioma, following the grant of … aggressive and fatal disease, Mesothelioma tends to spread along … role in tumor progression, metastasis, cancer metabolism, immunity and … for the treatment of mesothelioma. The designation would qualify …
-
Insilico Medicine received IND approval and orphan drug designation from FDA for ISM6331, an AI-designed TEAD inhibitor targeting solid tumors and mesothelioma
08 Aug 2024 14:54 GMT
… for the treatment of mesothelioma, following the grant of … aggressive and fatal disease, Mesothelioma tends to spread along … role in tumor progression, metastasis, cancer metabolism, immunity and … for the treatment of mesothelioma. The designation would qualify …
-
New Research Explores Uveal Melanoma Metastasis Mechanisms
23 Jul 2024 15:16 GMT
… metastasis, often to the liver, even years after initial diagnosis.
"Metastases … role in cancers such as mesothelioma and cholangiocarcinoma, its specific implications … in cancer cell metabolism during metastasis.
Future Directions in Treatment Strategies …
-
Study Takes a Closer Look at Eye Cancer’s High Rate of Metastasis
23 Jul 2024 10:16 GMT
… tumours within the eye.
Metastases of uveal melanoma could … after a diagnosis of metastases, is between 5 to … that drive uveal melanoma metastasis will likely uncover strategies … other cancer types such as mesothelioma and cholangiocarcinoma.
Subscribe to …